NORCLIFFE CAPITAL
Norcliffe Capital provides tax-efficient investments in the life science and disruptive technology sectors.
NORCLIFFE CAPITAL
Industry:
Financial Services
Status:
Active
Contact:
01892 263533
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-03-04 | Dxcover | Norcliffe Capital investment in Seed Round - Dxcover | 1.1 M GBP |
More informations about "Norcliffe Capital"
Norcliffe Capital Limited
Providing direct investment in ground-breaking life science companies. With decades of combined business experience in the life science sectors, Norcliffe Capital provides more than capital to …See details»
About - Norcliffe Capital Limited
With decades of combined business experience in the life science sectors, Norcliffe Capital provides more than capital to support our investments. We use our experience and expertise to select UK based growth companies in our …See details»
Norcliffe Capital - Crunchbase Investor Profile
Norcliffe Capital provides tax-efficient investments in the life science and disruptive technology sectors.See details»
Norcliffe Capital investment portfolio | PitchBook
Information on investments, active portfolio, exits, fund performance, dry powder, and co-investors for Norcliffe Capital. Use the PitchBook Platform to explore the full profile.See details»
Norcliffe Capital - Investments, Portfolio & Company Exits
Norcliffe Capital provides tax-efficient investments in the life science and disruptive technology sectors.See details»
Norcliffe Capital Limited - LinkedIn
Norcliffe Capital offers tax efficient ways to invest via the Enterprise Investment Scheme (EIS), SIPP, SSAS or a family investment company, as well as on a direct equity basis. Your capital is...See details»
Norcliffe Capital Investor Information - Funding, Portfolio …
Norcliffe Capital is a venture fund focused on seed-stage investments in health tech and biotech sectors. They invest in companies with proven intellectual property that aim for significant …See details»
Investors - Norcliffe Capital Limited
Capital Growth – Focused on providing exceptional capital growth. Transparency – We pride ourselves on our open and honest approach, providing comprehensive investor packs and …See details»
Norcliffe Capital | EIS - FS Ventures
Why Choose Norcliffe Capital? Capital Growth – Focused on providing meaningful capital growth for investors. Transparency – Norcliffe Capital pride themselves on their open and honest …See details»
Team - Norcliffe Capital Limited
As a venture capital firm specialising in medtech and biotech, we have the privilege of supporting the future of life science technology. Our investments are driven by a mission to make a meaningful impact on healthcare, whether it's …See details»
NORCLIFFE CAPITAL LIMITED - Companies House
NORCLIFFE CAPITAL LIMITED - Free company information from Companies House including registered office address, filing history, accounts, annual return, officers, charges, business …See details»
Norcliffe Capital Limited - Company Profile & Staff Directory
Norcliffe Capital works with financial advisers, wealth managers, family offices, private banks, accountants and individuals who are looking to directly invest in innovative UK companies. Our …See details»
NORCLIFFE CAPITAL LIMITED Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for NORCLIFFE CAPITAL LIMITED of LONDON. Get the latest business insights from Dun & Bradstreet.See details»
Oxford Endovascular secures £8 million to take novel brain …
May 20, 2024 · Parkwalk Advisors led the latest funding round investing £4.2 million alongside Norcliffe Capital, The University of Oxford, Oxford Science Enterprises (OSE) and Vulpes …See details»
Oxford University medtech spinout raises £8m in Series A+
May 20, 2024 · Oxford University medtech spinout Oxford Endovascular has completed an £8m Series A+ funding round led by Parkwalk Advisors, which invested £4.2m. Norcliffe Capital, …See details»
Portfolio - Norcliffe Capital Limited
We exceed our client’s expectations. Here, you can find some of the companies in our portfolio. Biosceptre International is a pharmaceutical company pioneering the development of a CAR-T …See details»
ClinSpec Diagnostics Closes £3.5M Funding - FinSMEs
Mar 4, 2021 · ClinSpec Diagnostics Limited, a Glasgow, Scotland, UK-based developer of liquid biopsies for early detection of cancer, secured an additional funding of £1.1M and closed its …See details»
Norcliffe Capital Fund Manager Profile - Preqin
Norcliffe Capital is a UK-based private equity firm that provides investments to help innovative companies within life science and disruptive technology sectors through growth acceleration. …See details»
Contact - Norcliffe Capital Limited
Ask us a question, browse our help content, or contact us directly through our contact form so we can give you a helping hand.See details»
ISO/DIS 14054(en) - ISO - International Organization for …
5.3 Describe the organization. 4.8 5.5 Select the type of natural capital account. 5.6 Undertake materiality assessment. 6 Collect data and conduct data quality assessment. 6.1 General. 6.4 …See details»